These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18179716)

  • 1. The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania.
    Njau JD; Goodman CA; Kachur SP; Mulligan J; Munkondya JS; McHomvu N; Abdulla S; Bloland P; Mills A
    Malar J; 2008 Jan; 7():4. PubMed ID: 18179716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.
    Yadav P; Cohen JL; Alphs S; Arkedis J; Larson PS; Massaga J; Sabot O
    Malar J; 2012 Aug; 11():299. PubMed ID: 22929587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    Mori AT; Norheim OF; Robberstad B
    Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.
    Cohen JL; Yadav P; Moucheraud C; Alphs S; Larson PS; Arkedis J; Massaga J; Sabot O
    PLoS One; 2013; 8(7):e70713. PubMed ID: 23923018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness study of three antimalarial drug combinations in Tanzania.
    Wiseman V; Kim M; Mutabingwa TK; Whitty CJ
    PLoS Med; 2006 Oct; 3(10):e373. PubMed ID: 17032059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs).
    Kindermans JM; Vandenbergh D; Vreeke E; Olliaro P; D'Altilia JP
    Malar J; 2007 Jul; 6():91. PubMed ID: 17623092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin combination therapies price disparity between government and private health sectors and its implication on antimalarial drug consumption pattern in Morogoro Urban District, Tanzania.
    Malisa AL; Kiriba D
    BMC Res Notes; 2012 Mar; 5():165. PubMed ID: 22455367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of malaria parasitemia and purchase of artemisinin-based combination therapies (ACTs) among drug shop clients in two regions in Tanzania with ACT subsidies.
    Briggs MA; Kalolella A; Bruxvoort K; Wiegand R; Lopez G; Festo C; Lyaruu P; Kenani M; Abdulla S; Goodman C; Kachur SP
    PLoS One; 2014; 9(4):e94074. PubMed ID: 24732258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005.
    Thwing JI; Njau JD; Goodman C; Munkondya J; Kahigwa E; Bloland PB; Mkikima S; Mills A; Abdulla S; Kachur SP
    Trop Med Int Health; 2011 Mar; 16(3):272-9. PubMed ID: 21226795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin resistance--modelling the potential human and economic costs.
    Lubell Y; Dondorp A; Guérin PJ; Drake T; Meek S; Ashley E; Day NP; White NJ; White LJ
    Malar J; 2014 Nov; 13():452. PubMed ID: 25418416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
    Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
    Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
    O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
    BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to artemisinin-based anti-malarial treatment and its related factors in rural Tanzania.
    Khatib RA; Selemani M; Mrisho GA; Masanja IM; Amuri M; Njozi MH; Kajungu D; Kuepfer I; Abdulla SM; de Savigny D
    Malar J; 2013 May; 12():155. PubMed ID: 23651521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Improving Community-Based Access to Malaria Diagnosis and Treatment on Household Costs.
    Castellani J; Nsungwa-Sabiiti J; Mihaylova B; Ajayi IO; Siribié M; Afonne C; Balyeku A; Sermé L; Sanou AK; Sombié BS; Tiono AB; Sirima SB; Kabarungi V; Falade CO; Kyaligonza J; Evers SM; Paulus AT; Petzold M; Singlovic J; Gomes M
    Clin Infect Dis; 2016 Dec; 63(suppl 5):S256-S263. PubMed ID: 27941102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of the malaria-related knowledge and practices of Tanzania's drug retailers: exploring the impact of drug store accreditation.
    Thomson R; Johanes B; Festo C; Kalolella A; Taylor M; Tougher S; Ye Y; Mann A; Ren R; Bruxvoort K; Willey B; Arnold F; Hanson K; Goodman C
    BMC Health Serv Res; 2018 Mar; 18(1):169. PubMed ID: 29523139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
    Larson BA; Amin AA; Noor AM; Zurovac D; Snow RW
    BMC Public Health; 2006 Dec; 6():314. PubMed ID: 17196105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.
    Thomson R; Festo C; Johanes B; Kalolella A; Bruxvoort K; Nchimbi H; Tougher S; Cairns M; Taylor M; Kleinschmidt I; Ye Y; Mann A; Ren R; Willey B; Arnold F; Hanson K; Kachur SP; Goodman C
    PLoS One; 2014; 9(5):e95607. PubMed ID: 24816649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania.
    Mulligan JA; Mandike R; Palmer N; Williams H; Abdulla S; Bloland P; Mills A
    Trop Med Int Health; 2006 Apr; 11(4):452-61. PubMed ID: 16553928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft targets or partners in health? Retail pharmacies and their role in Tanzania's malaria control program.
    Kamat VR; Nyato DJ
    Soc Sci Med; 2010 Aug; 71(3):626-633. PubMed ID: 20621751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.